Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307. (Q34553403)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307. |
scientific article |
Statements
Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307 (English)
Joseph J Eron
Ian Frank
Ronald J Bosch
Charles Flexner
Yoninah Segal
Ping Ruan
Roy Gulick
Kenneth Wood
Scharla Estep
Lawrence Fox
Thomas Nevin
Michael Stevens
ACTG 307 Protocol Team